Evaluation of Functional Outcomes at 2 Months According to Therapeutic Management, in Trauma With Low-grade Osteo-ligamentous Ankle Injury in Children (CHEVIPED)

March 1, 2024 updated by: University Hospital, Brest

Lack of current consensus on the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children. Several types of immobilization are evaluated in the literature, with different conclusions. Some teams recommend a functional treatment similar to the adult (with or without strict immobilization), others remain on standard rigid immobilizations.

The goal of the study is to simplify and homogenize the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children.

Study Overview

Detailed Description

Lack of current consensus on the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children. Several types of immobilization are evaluated in the literature, with different conclusions. Some teams recommend a functional treatment similar to the adult (with or without strict immobilization), others remain on standard rigid immobilizations.

The goal of the study is to simplify and homogenize the therapeutic management of low-grade osteo-ligament injuries in ankle trauma in children.

CHEVIPED is a controlled, randomized, comparative monocentric trial.

Randomization into 2 groups and stratified on presence to fracture Salter 1 and age

Experimental group : Patients with below-knee soft resin cast Control group : Patients with below-knee rigid resin cast.

The primary objective is to demonstrate at 2 months that with post traumatic low- grade osteo-ligamentous ankle injury the recovery of physical function are at least as effective with a below-knee soft resin cast compared to a below-knee rigid resin cast.

The secondary objectives are :

  1. Clinical evaluation of treatment at 3 weeks in immediate post-immobilization.
  2. Evaluation of the management satisfaction (effectiveness and understanding) and the treatment tolerance .
  3. Evaluation of the time taken to resume painless support after immobilization.
  4. Point of interest evaluation
  5. Determine the diagnostic performance of the "combined clinical criteria" in comparison with the ultrasound/radiography couple.
  6. Evaluation of the diagnostic performance of clinical inspection criteria (edema, bruise) in high-grade ligament damage.
  7. Evaluation of the link between the "combined clinical criteria" and the results of the radiography.
  8. Evaluation of the relationship between "combined clinical criteria" and ultrasound results.
  9. Evaluation of the link between the results of radiography and ultrasound.

200 patients are expected to be included.

Inclusion period : 12 months. Duration of patient's participation: 2 months Total study duration: 14 months.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brest, France, 29609
        • CHU de Brest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 15 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Walking child from 5 to 15 years old.
  • From hour 0 to hour 48 of ankle trauma with torsion mechanism (inversion, eversion or rotation).
  • Patient presenting for the first time to the emergency room for this traumatic episode.
  • Possibility of carrying out an ultrasound during the passage to the emergency room.
  • Child and parents' consent in the study participation

Exclusion Criteria:

  • Pubescent patients requiring anticoagulation (menarche in girls and genital pilosity in boys).
  • Direct shock on the foot without sprain mechanism.
  • Fracture with deformation or open fracture.
  • History of ankle trauma in the last 3 months.
  • Neurological or neuromuscular pathology.
  • Child with a delay in acquisitions and / or psychomotor development (difficulties in understanding and interacting to locate pain).
  • Absence of a representative of parental authority.
  • Constitutional bone disease or connective tissue.
  • Acquired or congenital coagulopathy.
  • Patient presenting beyond 48h of trauma.
  • Polytraumatized.
  • Dermabrasion, wound or sign of skin suffering next to the ankle requiring specific monitoring.
  • Child or parents refusal in study participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Below-knee soft resin cast

Below-knee soft resin cast is administered to participants in emergency department. Investigator puts three layers of jersey supplemented by strips of soft resins to be unrolled along the leg after immersion in warm water

Duration to ankle immobilization with soft resin boot : 21 days.

Patients have soft resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)
Other: Below-knee rigid resin cast

Below-knee soft resin cast is administered to participants in emergency department. Investigator puts one layer of jersey and then one layer of foam composed by strips of cotton wool to be unrolled supplemented by strips of rigid resins to be unrolled along the leg after immersion in warm water.

Duration to ankle immobilization with soft resin boot : 21 days.

Patients have rigid resin boot between day 0 (inclusion visit) and day 21 (follow-up visit n°1)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activities Scale for Kids (ASKp)
Time Frame: At 2 months
Activities Scale for Kids (ASKp) is a questionnaire about activities from the previous week. It has 30 item with 5 answers : all of the time (the better) / most of the time / sometimes / once in a while / none of the time (the worse).
At 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: day 0
It is a scale that measures pain intensity with small ruler, between 0 (no pain) to 10 (severe pain). It can be administered for children 4 to 6 years old.
day 0
Visual Analogue Scale (VAS)
Time Frame: day 21
It is a scale that measures pain intensity with small ruler, between 0 (no pain) to 10 (severe pain). It can be administered for children 4 to 6 years old.
day 21
Numeric Scale (NS)
Time Frame: day 0
It is a scale that mesures pain intensity. Children aged to 4 to 6 years gives a grade between 0 (no pain) to 10 (severe pain)
day 0
Numeric Scale (NS)
Time Frame: day 21
It is a scale that measures pain intensity. Children aged to 4 to 6 years gives a grade between 0 (no pain) to 10 (severe pain)
day 21
Clinical exams
Time Frame: day 0

Clinical exams are exams administered by investigator during a consultation. There are four exams :

  1. inspection : presence or not of a hematoma and oedema
  2. palpation : pain or not with palpation
  3. mobilization : 3 items with 2 answers (Yes/No)
  4. support capacity : 2 items with 2 answers (Yes/No)
day 0
Clinical exams
Time Frame: day 21

Clinical exams are exams administered by investigator during a consultation. There are four exams :

  1. inspection : presence or not of a hematoma and oedema
  2. palpation : pain or not with palpation
  3. mobilization : 3 items with 2 answers (Yes/No)
  4. support capacity : 2 items with 2 answers (Yes/No)
day 21
Parents questionnaire
Time Frame: day 21
It is a questionnaire for parents that assesses the feeling about the children care, with 3 questions.
day 21
Intercurrent consultation
Time Frame: between day 0 and day 42
Adjudicated intercurrent consultation (Other medical consultation than those planned) during the study treatment period
between day 0 and day 42
injury during removal of the device
Time Frame: between day 0 and day 42
Adjudicated injury during removal of the device during the study treatment period
between day 0 and day 42
Negative predictive value (VPN) of "combined clinical criteria"
Time Frame: day 0
Negative predictive value (VPN) of "combined clinical criteria" in the detection of low-grade bone or ligament damage to the ankle in children compared to ultrasound/radiography.
day 0
Sensitivity and specificity of local skin signs
Time Frame: day 0
Sensitivity and specificity of local skin signs (INSPECTION line of the clinical examination questionnaire) to detect high-grade ligament damage on ultrasound.
day 0
Comparison between clinical exams and the radiography results.
Time Frame: day 0
Clinical exams are exams administred by investigator during a consultation (inspection, palpation, mobilization, support capacity).The results of this exams are compared to radiography results at the inclusion (origin and localization of injury)
day 0
Comparison between the clinical exams and the ultrasound results.
Time Frame: day 0
Clinical exams are exams administred by investigator during a consultation (inspection, palpation, mobilization, support capacity).The results of this exams are compared to ultrasound results at the inclusion (origin and localization of injury) .
day 0
Comparison between the radiography results and the ultrasound results.
Time Frame: day 0
Ultrasound results are compared to radiography results at the inclusion (origin and localization of injury) .
day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2021

Primary Completion (Actual)

June 9, 2023

Study Completion (Actual)

June 9, 2023

Study Registration Dates

First Submitted

August 6, 2021

First Submitted That Met QC Criteria

August 11, 2021

First Posted (Actual)

August 17, 2021

Study Record Updates

Last Update Posted (Actual)

March 4, 2024

Last Update Submitted That Met QC Criteria

March 1, 2024

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected data that underlie results in a publication

IPD Sharing Time Frame

Data will be available after the publication of result and ending fifteen years following the last visit of the last patient

IPD Sharing Access Criteria

Data access requests will be reviewed by the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Injuries

Clinical Trials on below-knee soft resin cast

Subscribe